Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Effecty vs RxSpan MD

By GLP-1 ScorecardUpdated

Effecty
Site position #21

Lower grade

RxSpan MD
Site position #5

Higher grade

Score comparison

RxSpan MD has the higher recorded score — 84.3/100 to 83.7/100, but only just.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling. Effecty is close behind and may still be the better fit — see the factor split below.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRxSpan MD +6
80
86
Dose & formulationRxSpan MD +5
84
89
Clinical oversightRxSpan MD +3
85
88
Labs & monitoringEffecty +1
84
83
FulfillmentRxSpan MD +2
87
89
Contract termsEffecty +33
86
53
Effecty · top barRxSpan MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEffectyRxSpan MD
WeighScore83.7/10084.3/100
GradeBB
Site position#21#5
Semaglutide$160/moCurrent compounded quote unconfirmed
Tirzepatide$240/moCurrent compounded quote unconfirmed
CoverageAll 50 statesConfirm treatment availability during intake
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Effecty

Site position #21 · B

Strengths

  • Brand-name access
  • LegitScript-verified, all 50 states
  • Both molecules

What to consider

  • Higher pricing ($160/$240)
  • Injection-only
  • Not a value leader
RxSpan MD

Site position #5 · B

Strengths

  • Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
  • Public terms describe independent healthcare providers
  • Homepage describes messaging and care-team appointments

What to consider

  • Homepage advertises compounded plans that the current catalog did not substantiate
  • Current oral GLP-1 availability is unconfirmed
  • Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
  • Public terms do not establish unused prepaid-treatment refund amounts

Featured provider

RxSpan MD

RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard